Evolution Wealth Advisors’s BioAtla BCAB Stock Holding History

Evolution Wealth Advisors’s Portfolio BCAB Stock Details BCAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-2	Closed	-$3K	–	201
2021 Q3	$3K	Sell	2 -2	-50%	-$3.9K	﹤0.01%	592
2021 Q2	$9K	Hold	4	–	–	﹤0.01%	420
2021 Q1	$11K	Sell	4 -2	-33%	-$5.13K	﹤0.01%	396
2020 Q4	$10K	Buy	+6	New	+$10K	﹤0.01%	348

Other funds holding BCAB

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Evolution Wealth Advisors's BCAB Position: Q4 2021 in Review

Evolution Wealth Advisors sold out of BioAtla (BCAB) in Q4 2021, closing a stake of 2 shares — an estimated $3K sold.

Evolution Wealth Advisors first reported a position in BCAB in Q4 2020 and held it in 4 quarters. The position peaked at $11K in Q1 2021. 79 funds tracked by Wall St. Rank hold BCAB as of Q4 2021.

Evolution Wealth Advisors reported no remaining BioAtla position as of Q4 2021 after selling out during the quarter.
Evolution Wealth Advisors sold 2 BioAtla shares in Q4 2021, an estimated $3K.
Evolution Wealth Advisors first reported a position in BioAtla in Q4 2020 and held it in 4 quarters.
Evolution Wealth Advisors's BioAtla position peaked at $11K in Q1 2021.
79 funds tracked by Wall St. Rank held BioAtla as of Q4 2021.

Based on Evolution Wealth Advisors's 13F filing for Q4 2021, filed 28 Jan 2022.